Search
for
Sort by
Research 301–330 of 569
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Diseases of Periocular Hair
- Airborne contact dermatitis apparently acquired as a result of using pericarp juice from an Indian marking nut as a home remedy to treat patchy hair loss
- Bilateral Eyelash Poliosis with Raccoon Erythema and Hypopigmentation-Contact Follicular Leukoderma
- Homoeopathic treatment of hypothyroidism: A case report
- Systemic Lupus Erytomatosa in Pregnancy Accompained by Angioedema
- An Interesting Case of X-linked Hypohidrotic Ectodermal Dysplasia
- A case of demodicosis in a dog successfully managed with Nexgard®
- The Siblings with Blistered Legs: Marking Nut Maladies in India
- Skin diseases associated with Agent Orange and other organochlorine exposures.
- Cutaneous Drug Reaction Case Reports
- Alopecia associated with syringomas
- Cutaneous complications of chemotherapeutic agents
- Clinical manifestations of cutaneous lupus erythematosus
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- Cutaneous reactions to recombinant cytokine therapy
- Biology and Genetics of Hair
- Dermatologic manifestations of endocrine disorders
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- Cutaneous lupus erythematosus
- Acquired Zinc Deficiency
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- TREATMENT OF ALOPECIA AREATA
- 3D printed microneedles: revamping transdermal drug delivery systems
- Disrupted Ectodermal Organ Morphogenesis in Mice with a Conditional Histone Deacetylase 1, 2 Deletion in the Epidermis
- Cutaneous Lesions in Systemic Lupus Erythematosus
- The eyelash follicle features and anomalies: A review
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge